Gel
capsules of saw palmetto may improve the symptoms of enlarged prostate, a new
study reports.
Saw
palmetto (Serenoa repens) is used popularly in Europe for the management
of symptoms associated with benign prostatic hypertrophy (enlarged prostate).
Although not considered standard of care in the United States, it is the most
popular phytotherapy for this indication.
Numerous
controlled trials have reported saw palmetto to be superior to placebo and
possibly equivalent to the anti-androgenic agent finasteride/Proscar® (with
fewer adverse effects) in the alleviation of nocturia (the need to frequently
urinate at night), improvement of urinary flow, reduction of post-void residual
bladder volume and improvement of quality of life (but possibly not measurable
reduction in prostate size).
Saw
palmetto was listed in the United States Pharmacopeia from 1906 to 1917 and in
the National Formulary from 1926 to 1950.
Researchers
from the People's Republic of China investigated the effect of Prostataplex™ (a
saw palmetto gel capsule) in men with lower urinary tract symptoms associated
with benign prostatic hyperplasia.
Researchers
randomly assigned a total of 92 Chinese men between 49 and 75 years old with
lower urinary tract symptoms to the intervention group (46 patients) or the
control group (46 patients). The intervention group patients were given two
Prostataplex™ soft gels daily for 12 weeks, and the control group patients were
given two placebo soft gels for the same time.
The
researchers found that after 12 weeks of intervention, the mean urinary flow
rate was significantly higher in the treatment group than in the control group,
while relative urinary resistance was significantly lower in the treatment
group than in the control group. While there was no significant difference in
mean prostate volume or International Prostate Symptom Score between the two
groups, 18 of 46 patients (39.1 percent) in the treatment group showed an
International Prostate Symptom Score improvement (decrease of three or greater)
after intervention, whereas only one of 46 (2.2 percent) in the control group
showed an International Prostate Symptom Score improvement.
The
study authors concluded that Prostataplex™ may have short-term effects in
improving symptoms and objective measures in Chinese men with lower urinary
tract symptoms associated with benign prostatic hyperplasia.
For
more information about saw palmetto, please visit Natural Standard’s Foods,
Herbs & Supplements database.